Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, C.-I
Right arrow Articles by Kuo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, C.-I
Right arrow Articles by Kuo, L.
[Cancer Research 61, 1100-1106, February 1, 2001]
© 2001 American Association for Cancer Research


Immunology

Macrophage Arginase Promotes Tumor Cell Growth and Suppresses Nitric Oxide-mediated Tumor Cytotoxicity1

Chiung-I Chang, James C. Liao and Lih Kuo2

Department of Medical Physiology, Cardiovascular Research Institute, Texas A&M University System Health Science Center, College Station, Texas 77843-1114 [C-I. C., L. K.], and Department of Chemical Engineering, University of California, Los Angeles, California 90095-1592 [J. C. L.]

Macrophages use L-arginine to synthesize nitric oxide (NO) and polyamines through the inducible NO synthase (iNOS) and arginase, respectively. The released NO contributes to the tumoricidal activity of macrophages, whereas polyamines may promote the growth of tumor cells. Both the tumoricidal and growth-promoting activities from macrophages have been reported; however, the underlying mechanisms for switching between this dual function of macrophages remain unclear. Here, we test the hypothesis that arginase participates in the switching between the cytotoxic and growth-promoting activities of macrophages toward tumor cells. To alter arginase activity in macrophages, cells (murine macrophage cell line J774A.1) were transfected with the rat liver arginase gene or treated with an arginase inhibitor, L-norvaline. The effects of macrophage arginase activity on the growth-promoting and cytotoxic activities of macrophages toward breast tumor cells (ZR-75–1) were investigated in a coculture system. The results demonstrated that overexpression of arginase in macrophages enhanced L-ornithine and putrescine production and consequently promoted tumor cell proliferation. This proliferative effect was down-regulated by the arginase inhibitor L-norvaline. Furthermore, increases in arginase activity also attenuated NO production by the lipopolysaccharide-activated macrophages and thus reduced the cytotoxic effect on cocultured tumor cells. Inhibiting arginase activity by L-norvaline effectively reversed the suppression of NO-mediated tumor cytotoxicity. Together, these results suggest that arginase induction in macrophages can enhance tumor cell growth by providing them with polyamines and suppress tumor cytotoxicity by reducing NO production. It appears that L-arginine metabolism through the arginase and iNOS pathways in macrophages can have very different influences on the growth of nearby tumor cells depending on which pathway is prevailing.




This article has been cited by other articles:


Home page
IOVSHome page
K. C. McKenna, K. M. Beatty, R. A. Bilonick, L. Schoenfield, K. L. Lathrop, and A. D. Singh
Activated CD11b+ CD15+ Granulocytes Increase in the Blood of Patients with Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., September 1, 2009; 50(9): 4295 - 4303.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Kotamraju, C. L. Willams, and B. Kalyanaraman
Statin-Induced Breast Cancer Cell Death: Role of Inducible Nitric Oxide and Arginase-Dependent Pathways
Cancer Res., August 1, 2007; 67(15): 7386 - 7394.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. J. Bivalacqua, A. L. Burnett, W. J. G. Hellstrom, and H. C. Champion
Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1340 - H1351.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. B. Frey and N. Monu
Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response
J. Leukoc. Biol., April 1, 2006; 79(4): 652 - 662.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. C. Rodriguez, C. P. Hernandez, D. Quiceno, S. M. Dubinett, J. Zabaleta, J. B. Ochoa, J. Gilbert, and A. C. Ochoa
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
J. Exp. Med., October 3, 2005; 202(7): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Di Costanzo, G. Sabio, A. Mora, P. C. Rodriguez, A. C. Ochoa, F. Centeno, and D. W. Christianson
Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response
PNAS, September 13, 2005; 102(37): 13058 - 13063.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
V. Bronte, T. Kasic, G. Gri, K. Gallana, G. Borsellino, I. Marigo, L. Battistini, M. Iafrate, T. Prayer-Galetti, F. Pagano, et al.
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
J. Exp. Med., April 18, 2005; 201(8): 1257 - 1268.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kusmartsev and D. I. Gabrilovich
STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion
J. Immunol., April 15, 2005; 174(8): 4880 - 4891.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Chen, B. C. McCaig, M. Melotto, S. Y. He, and G. A. Howe
Regulation of Plant Arginase by Wounding, Jasmonate, and the Phytotoxin Coronatine
J. Biol. Chem., October 29, 2004; 279(44): 45998 - 46007.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Mori and T. Gotoh
Arginine Metabolic Enzymes, Nitric Oxide and Infection
J. Nutr., October 1, 2004; 134(10): 2820S - 2825S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. C. Rodriguez, D. G. Quiceno, J. Zabaleta, B. Ortiz, A. H. Zea, M. B. Piazuelo, A. Delgado, P. Correa, J. Brayer, E. M. Sotomayor, et al.
Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses
Cancer Res., August 15, 2004; 64(16): 5839 - 5849.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. G. Chicoine, M. L. Paffett, T. L. Young, and L. D. Nelin
Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells
Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L60 - L68.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kusmartsev, Y. Nefedova, D. Yoder, and D. I. Gabrilovich
Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species
J. Immunol., January 15, 2004; 172(2): 989 - 999.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. El-Gayar, H. Thuring-Nahler, J. Pfeilschifter, M. Rollinghoff, and C. Bogdan
Translational Control of Inducible Nitric Oxide Synthase by IL-13 and Arginine Availability in Inflammatory Macrophages
J. Immunol., November 1, 2003; 171(9): 4561 - 4568.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. C. Rodriguez, A. H. Zea, J. DeSalvo, K. S. Culotta, J. Zabaleta, D. G. Quiceno, J. B. Ochoa, and A. C. Ochoa
L-Arginine Consumption by Macrophages Modulates the Expression of CD3{zeta} Chain in T Lymphocytes
J. Immunol., August 1, 2003; 171(3): 1232 - 1239.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Liu, J. A. Van Ginderachter, L. Brys, P. De Baetselier, G. Raes, and A. B. Geldhof
Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells
J. Immunol., May 15, 2003; 170(10): 5064 - 5074.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Bronte, P. Serafini, C. De Santo, I. Marigo, V. Tosello, A. Mazzoni, D. M. Segal, C. Staib, M. Lowel, G. Sutter, et al.
IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
J. Immunol., January 1, 2003; 170(1): 270 - 278.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. C. Rodriguez, A. H. Zea, K. S. Culotta, J. Zabaleta, J. B. Ochoa, and A. C. Ochoa
Regulation of T Cell Receptor CD3zeta Chain Expression by L-Arginine
J. Biol. Chem., June 7, 2002; 277(24): 21123 - 21129.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Raes, P. De Baetselier, W. Noel, A. Beschin, F. Brombacher, and G. Hassanzadeh Gh.
Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages
J. Leukoc. Biol., April 1, 2002; 71(4): 597 - 602.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. P. Gobert, D. J. McGee, M. Akhtar, G. L. Mendz, J. C. Newton, Y. Cheng, H. L. T. Mobley, and K. T. Wilson
Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival
PNAS, November 20, 2001; 98(24): 13844 - 13849.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.